|
2025
|
Invention
|
Methods of producing bioconjugates of e. coli o-antigen polysaccharides, compositions thereof, an... |
|
|
Invention
|
Mdr e. coli immunogen.
The subject relates to an isolated antibody that specifically binds to O2... |
|
|
Invention
|
Compositions comprising aticaprant.
The present disclosure relates to compositions, including or... |
|
|
Invention
|
Multivalent vaccine compositions and uses thereof.
Compositions and methods are described for in... |
|
|
Invention
|
Liposomes containing phosphorylated tau peptides for inducing sustained immune responses.
Method... |
|
2024
|
Invention
|
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors.
The present i... |
|
|
Invention
|
Anti-respiratory syncytial virus antibodies and uses thereof. Provided herein are antibodies and ... |
|
|
Invention
|
Systems and methods for sterilizing mass flow meters and their use for precise pharmaceutical con... |
|
|
Invention
|
Tau active functional assays. The application describes methods for evaluating the capacity of an... |
|
|
Invention
|
Method of treating preclinicial alzheimer's disease. The application describes a phosphorylated t... |
|
|
Invention
|
Method of treating preclinicial alzheimer's disease.
The application describes a phosphorylated ... |
|
|
Invention
|
Compositions comprising aticaprant for use in treating major depressive disorder. The present dis... |
|
|
Invention
|
Method for quantifying bound acetate in glycoconjugates. The present invention relates to a metho... |
|
|
Invention
|
Intranasal administration of esketamine.
The present invention is directed to pharmaceutical pro... |
|
|
Invention
|
Forms of aticaprant. The disclosure provides crystalline and amorphous forms of aticaprant. Also ... |
|
|
Invention
|
Fimh mutant, compositions therewith and use thereof.
Polypeptides comprising a FimH lectin domai... |
|
|
Invention
|
Compositions comprising aticaprant. The present disclosure relates to compositions, including ora... |
|
|
Invention
|
Compositions and methods for the treatment of depression. The disclosure provides methods for tre... |
|
|
Invention
|
Bioconjugates of e. coli o-antigen polysaccharides, methods of production thereof, and methods of... |
|
2023
|
Invention
|
Bioconjugate compositions and process for bioconjugate production. The present invention relates ... |
|
|
Invention
|
Multivalent vaccine compositions and uses thereof. Compositions and methods are described for ind... |
|
|
Invention
|
Expec glycoconjugate vaccine formulations.
Compositions and methods for inducing an immune respo... |
|
|
Invention
|
Compositions and methods for enhancing gene expression.
The present disclosure generally relates... |
|
|
Invention
|
Induce and enhance immune responses using recombinant replicon systems.
The present disclosure g... |
|
|
Invention
|
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors. The present in... |
|
|
Invention
|
Esketamine for the treatment of depression.
The present invention provides methods of maintainin... |
|
|
Invention
|
Fimh mutants, compositions therewith and use thereof. Polypeptides comprising a FimH lectin domai... |
|
|
Invention
|
Method of safe administration of phosphorylated tau peptide vaccine. Methods for inducing anti-ph... |
|
|
Invention
|
Treatment or prevention of dengue viral infection. The present invention relates to a compound of... |
|
|
Invention
|
Treatment or prevention of dengue viral infection. 1233132331233313231332313233132333. |
|
|
Invention
|
Smart liquid drug administration.
In general, devices, systems, and methods of smart liquid drug... |
|
|
Invention
|
Compositions and methods for the treatment of depression.
The disclosure provides methods for tr... |
|
2022
|
Invention
|
Anti-human vista antibodies and use thereof.
The invention provides antagonistic and agonistic a... |
|
|
Invention
|
Method of safe administration of tau phosphopeptide conjugate.
Methods for inducing anti-phospho... |
|
|
Invention
|
Processes for the preparation of (s)-2-(4-chloro-2-methoxyphenyl)-2-((3 -methoxy-5-(m ethylsulfon... |
|
|
Invention
|
Single vial holder |
|
|
Invention
|
Dual vial holder |
|
|
Invention
|
Process for bioconjugate production.
The present invention relates to a process for the producti... |
|
2021
|
Invention
|
Solid formulation.
The invention relates to pharmaceutical formulations comprising an active pha... |
|
|
Invention
|
Variant staphylococcus aureus luka and lukb polypeptides and vaccine compositions.
The present d... |
|
|
Invention
|
Stabilized coronavirus spike protein fusion proteins.
The present invention provides stabilized ... |
|
2020
|
Invention
|
Drug delivery adjustment.
Provided herein are drug administration devices, methods, and systems ... |
|
|
Invention
|
Drug administration device and system for establishing a dosage regimen and compatibility of comp... |
|
2019
|
G/S
|
Pharmaceutical preparations, in particular for the treatment of multiple sclerosis. |
